The IPO Buzz: A Single Rose Before Summer Ends
The last rose of summer appears on this week’s IPO Calendar and then Wall Street is off to vacation land until after Labor Day. The $28 million deal, set for pricing on Monday night, is slated for Tuesday’s trading. The IPO is Aridis Pharmaceuticals (ARDS proposed), based in San Jose, California. It is a late-stage biopharmaceutical company formed to discover targeted immunotherapies for life..
Read more August 12, 2018IPO Calendar
| Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
|---|---|---|---|---|---|---|
| Aridis Pharmaceuticals | ARDS | 2.0 | $ 26.0 mil | 8/14/2018 Priced | S/O | S/O |
Last 100 IPOs - August 13, 2018
| Number of IPOs priced : | 100 |
| Number Up: | 58 |
| Number Down: | 41 |
| Number Unchanged: | 1 |
| Percentage Change From Issue Price: | 23.10% |
| Percentage Change for The Nasdaq Composite | 13.75% |
2018 IPO Scorecard - August 13, 2018
| Number of IPOs priced (Excluding 30 units) : | 129 |
| Number Up: | 74 |
| Number Down: | 54 |
| Number Unchanged: | 1 |
| Total Return From Issue Price: | 22.67% |
| The Nasdaq Composite Index YTD % Change | 13.27% |